Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 384

1.

Robert Kisilevsky, MD, PhD, 1937-2019.

Bellotti V, Merlini G, Westermark P.

Amyloid. 2019 Dec;26(4):179. doi: 10.1080/13506129.2019.1660158. Epub 2019 Sep 4. No abstract available.

PMID:
32054319
2.

A powerful oral triplet for AL amyloidosis.

Palladini G, Milani P, Merlini G.

Br J Haematol. 2020 Feb 3. doi: 10.1111/bjh.16471. [Epub ahead of print] No abstract available.

PMID:
32011727
3.

Here to Stay: Biosimilars in Hematology.

Gribben J, Merlini G, Hagenbeek A.

Hemasphere. 2019 Nov 19;3(6):e323. doi: 10.1097/HS9.0000000000000323. eCollection 2019 Dec. No abstract available.

4.

An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins.

Jacobs JFM, Turner KA, Graziani MS, Frinack JL, Ettore MW, Tate JR, Booth RA, McCudden CR, Keren DF, Delgado JC, Zemtsovskaja G, Fullinfaw RO, Caldini A, de Malmanche T, Katakouzinos K, Burke M, Palladini G, Altinier S, Zaninotto M, Righetti G, Melki MT, Bell S, Willrich MAV.

Clin Chem Lab Med. 2020 Jan 15. pii: /j/cclm.ahead-of-print/cclm-2019-1105/cclm-2019-1105.xml. doi: 10.1515/cclm-2019-1105. [Epub ahead of print]

PMID:
31940285
5.

An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis.

Turner KA, Frinack JL, Ettore MW, Tate JR, Graziani MS, Jacobs JFM, Booth RA, McCudden CR, Keren DF, Delgado JC, Zemtsovskaja G, Fullinfaw RO, Caldini A, de Malmanche T, Katakouzinos K, Burke M, Palladini G, Altinier S, Zaninotto M, Righetti G, Melki MT, Bell S, Willrich MAV.

Clin Chem Lab Med. 2020 Jan 15. pii: /j/cclm.ahead-of-print/cclm-2019-1104/cclm-2019-1104.xml. doi: 10.1515/cclm-2019-1104. [Epub ahead of print]

PMID:
31940284
6.

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.

Adams D, Ando Y, Beirão JM, Coelho T, Gertz MA, Gillmore JD, Hawkins PN, Lousada I, Suhr OB, Merlini G.

J Neurol. 2020 Jan 6. doi: 10.1007/s00415-019-09688-0. [Epub ahead of print] Review.

PMID:
31907599
7.

Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathy.

Maia LF, Maceski A, Conceição I, Obici L, Magalhães R, Cortese A, Leppert D, Merlini G, Kuhle J, Saraiva MJ.

Amyloid. 2020 Jan 6:1-6. doi: 10.1080/13506129.2019.1708716. [Epub ahead of print]

PMID:
31906707
8.

Inherent Biophysical Properties Modulate the Toxicity of Soluble Amyloidogenic Light Chains.

Maritan M, Romeo M, Oberti L, Sormanni P, Tasaki M, Russo R, Ambrosetti A, Motta P, Rognoni P, Mazzini G, Barbiroli A, Palladini G, Vendruscolo M, Diomede L, Bolognesi M, Merlini G, Lavatelli F, Ricagno S.

J Mol Biol. 2019 Dec 24. pii: S0022-2836(19)30715-6. doi: 10.1016/j.jmb.2019.12.015. [Epub ahead of print]

PMID:
31874151
9.

Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis.

Coelho T, Yarlas A, Waddington-Cruz M, White MK, Sikora Kessler A, Lovley A, Pollock M, Guthrie S, Ackermann EJ, Hughes SG, Karam C, Khella S, Gertz M, Merlini G, Obici L, Schmidt HH, Polydefkis M, Dyck PJB, Brannagan Iii TH, Conceição I, Benson MD, Berk JL.

J Neurol. 2019 Dec 18. doi: 10.1007/s00415-019-09671-9. [Epub ahead of print]

PMID:
31853709
10.

Amyloidosis and Ocular Involvement: an Overview.

Dammacco R, Merlini G, Lisch W, Kivelä TT, Giancipoli E, Vacca A, Dammacco F.

Semin Ophthalmol. 2019 Dec 12:1-20. doi: 10.1080/08820538.2019.1687738. [Epub ahead of print]

PMID:
31829761
11.

Amyloidosis in Heart Failure.

Ihne S, Morbach C, Obici L, Palladini G, Störk S.

Curr Heart Fail Rep. 2019 Dec;16(6):285-303. doi: 10.1007/s11897-019-00446-x. Review.

PMID:
31782077
12.

Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis.

Basset M, Defrancesco I, Milani P, Nuvolone M, Rattotti S, Foli A, Mangiacavalli S, Varettoni M, Benvenuti P, Cartia CS, Paulli M, Merlini G, Arcaini L, Palladini G.

Blood. 2020 Jan 23;135(4):293-296. doi: 10.1182/blood.2019002762. No abstract available.

PMID:
31714952
13.

Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance.

Chattopadhyay S, Thomsen H, Weinhold N, Meziane I, Huhn S, da Silva Filho MI, Vodicka P, Vodickova L, Hoffmann P, Nöthen MM, Jöckel KH, Schmidt B, Landi S, Hajek R, Hallmans G, Pettersson-Kymmer U, Ohlsson C, Milani P, Merlini G, Rowcieno D, Hawkins P, Hegenbart U, Palladini G, Wechalekar A, Schönland SO, Houlston R, Goldschmidt H, Hemminki K, Försti A.

Leukemia. 2019 Nov 6. doi: 10.1038/s41375-019-0619-1. [Epub ahead of print] No abstract available.

PMID:
31695157
14.

Light Chains With Heavy Effects.

Obici L, Merlini G.

Am J Kidney Dis. 2020 Feb;75(2):291-293. doi: 10.1053/j.ajkd.2019.08.009. Epub 2019 Oct 16. No abstract available.

PMID:
31629574
15.

An evaluation of patisiran: a viable treatment option for transthyretin-related hereditary amyloidosis.

Milani P, Mussinelli R, Perlini S, Palladini G, Obici L.

Expert Opin Pharmacother. 2019 Dec;20(18):2223-2228. doi: 10.1080/14656566.2019.1671352. Epub 2019 Sep 30. Review.

PMID:
31566422
16.

Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.

Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G.

Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4.

PMID:
31480867
17.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Card Fail. 2019 Nov;25(11):e1-e39. doi: 10.1016/j.cardfail.2019.08.001. Epub 2019 Aug 29. No abstract available.

PMID:
31473268
18.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Card Fail. 2019 Nov;25(11):854-865. doi: 10.1016/j.cardfail.2019.08.002. Epub 2019 Aug 29.

PMID:
31473267
19.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Nucl Cardiol. 2019 Aug 29. doi: 10.1007/s12350-019-01761-5. [Epub ahead of print]

PMID:
31468377
20.

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.

J Nucl Cardiol. 2019 Dec;26(6):2065-2123. doi: 10.1007/s12350-019-01760-6. No abstract available.

PMID:
31468376

Supplemental Content

Loading ...
Support Center